NeOnc Technologies Holdings, Inc. Common Stock
NASDAQ: NTHI · HEALTHCARE · BIOTECHNOLOGY
Updated 2026-09-22
NeOnc Technologies Holdings, Inc. Common Stock (NTHI) Financial statements
SEC filings — annual and quarterly data.
Margin trends — annual
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-3.38M | — | — | — |
| 2022 | $20000.00 | $-3.05M | 100.00% | -14,188.02% | -15,233.79% |
| 2023 | $70462.00 | $-14.92M | 100.00% | -17,310.99% | -21,176.05% |
| 2024 | $83000.00 | $-11.90M | 100.00% | -8,605.45% | -14,335.50% |
| 2025 | $39990.00 | $-62.15M | 100.00% | -145,459.36% | -155,404.38% |
Frequently asked questions
What is NeOnc Technologies Holdings, Inc. Common Stock's revenue?
NeOnc Technologies Holdings, Inc. Common Stock's trailing twelve-month revenue is $39990.00. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.
How profitable is NTHI?
In its most recent fiscal year, NTHI ran a gross margin of 100.00%, an operating margin of -145,459.36%, and a net margin of -155,404.38%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.
How much free cash flow does NTHI generate?
NTHI produced $-20.86M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.
Is NTHI's balance sheet healthy?
NTHI holds $58729.00 in cash and equivalents against — in long-term debt, on $-17.51M of shareholder equity. That debt is best read against the cash flow the business throws off each year.